Reagents News and Research

RSS

Novel label-free imaging method can differentiate active T cells from those off duty

T cells are the immune soldiers at the frontlines of the battle with infiltrating pathogens that seek to cause disease. A new study published in Nature Biomedical Engineering describes a novel label-free imaging technique that can differentiate active T cells from those off duty.

27 Jul 2020

Alternative amplification technique could accelerate COVID-19 testing

An alternative amplification technique to detect SARS-CoV-2 RNA could offer a way to rapidly test large numbers of people for COVID-19, although the technique is not as sensitive as quantitative RT-PCR, the current standard method for COVID-19 testing.

27 Jul 2020

New approach could enable wider adoption of COVID-19 testing for diagnosis in research laboratories

Clinician-scientists at Nanyang Technological University, Singapore's (NTU Singapore) Lee Kong Chian School of Medicine (LKCMedicine) have demonstrated a way to improve the speed, handling time and cost of COVID-19 laboratory tests.

27 Jul 2020

Ultivue and OracleBio partner to help advance personalized tumor characterization and clinical oncology research using multiplex immunofluorescence

Ultivue and OracleBio partner to help further insights and advance personalized tumor characterization in translational and clinical oncology research.

From Ultivue 23 Jul 2020

States search for ways to deal with COVID-19 testing backlogs

States frustrated by private laboratories' increasingly long turnarounds for COVID-19 test results are scrambling to find ways to salvage their testing programs.

23 Jul 2020

Avacta provides update on clinical validation of Adeptrix COVID-19 diagnostic test

Avacta is pleased to announce that it has begun work with the UK government’s CONDOR program to evaluate and clinically validate the COVID-19 laboratory assay.

22 Jul 2020

Avacta provides update on clinical validation of Adeptrix COVID-19 diagnostic test

Avacta is pleased to announce that it has begun work with the UK government’s CONDOR program to evaluate and clinically validate the COVID-19 laboratory assay.

22 Jul 2020

Promega Maxwell Extraction System added to CDC COVID-19 diagnostic protocol

Promega Corporation’s Maxwell RSC 48 Instrument and Maxwell RSC Viral Total Nucleic Acid Purification Kit are now in the Centers for Disease Control and Prevention’s COVID-19 diagnostic protocol for emergency use.

From Promega Corporation 21 Jul 2020

New assay improves detection of SARS-CoV-2 antibodies

Researchers at the University of California Santa Cruz have developed a new assay for the detection of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that they say provides significant advantages over the techniques currently used.

20 Jul 2020

Avacta and Integumen team up for detection of novel coronavirus in waste water

Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has entered into a collaboration with Integumen plc (“Integumen”) to evaluate recently generated Affimer reagents that bind the SARS-COV-2 spike protein for the detection of the coronavirus in wastewater, to provide a real-time alert system to warn of localized COVID-19 outbreaks.

From Avacta Life Sciences Ltd. 14 Jul 2020

Absolute Antibody and University of Zurich partner to offer novel SARS-CoV-2 sybodies

Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with University of Zurich to offer synthetic nanobodies against the receptor binding domain (RBD) of SARS-CoV-2, the coronavirus that causes COVID-19.

From Absolute Antibody Ltd 14 Jul 2020

Fully automated chip can reliably determine blood type within minutes

The need to first zero in on a blood group can delay blood transfusions in emergency situations, and this in turn can prove fatal.

13 Jul 2020

LGC acquires The Native Antigen Company, strengthening its offer to the IVD sector

Today, LGC announced the acquisition of The Native Antigen Company (NAC), one of the world’s leading suppliers of high quality infectious disease antigens and antibodies.

9 Jul 2020

Horizon Discovery introduces Cas9 and dCas9-VPR stable cell lines to simplify and accelerate CRISPR gene editing workflows

Horizon Discovery Group plc, today announced the introduction of its stably expressing Cas9 and dCas9-VPR cell lines to help accelerate gene knockout.

8 Jul 2020

Cancer Research UK and Abcam launch custom partnership to accelerate cancer research

Today, Cancer Research UK, the world’s largest independent funder of cancer research and Abcam plc, a global innovator in life science reagents and tools, are pleased to announce a new partnership for the development and commercialization of novel custom antibodies to support the acceleration of cancer research.

From Abcam 7 Jul 2020

New tool to increase accessibility for COVID-19 testing

A research group from the University of California Santa Barbara recently demonstrated a cost-effective, simple, and much less toxic method to isolate host and pathogen nucleic acids and proteins in order to streamline the detection of DNA and RNA viruses – including the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

1 Jul 2020

Study: Even the sickest COVID-19 patients produce T cells that help fight the virus

A new study from researchers at La Jolla Institute for Immunology (LJI) and Erasmus University Medical Center (Erasmus MC) shows that even the sickest COVID-19 patients produce T cells that help fight the virus.

30 Jun 2020

BATM provides business and trading update

BATM, a leading provider of real-time technologies for networking solutions and medical laboratory systems, provides the following business and trading update.

26 Jun 2020

Kerafast offers the Delta-G-VSV Pseudotyping System for coronavirus research

Kerafast Inc., developers of an online platform to facilitate access to unique lab-made bioresearch materials, today announced the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, developed by the Michael Whitt laboratory at University of Tennessee, enables studies of SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) containment.

From Kerafast 24 Jun 2020

Avacta provides update on COVID-19 rapid antigen test development partnership with Cytiva

Avacta Group plc is pleased to announce that the rapid test strips to detect SARS-COV-2 spike protein have been evaluated by Avacta’s partners at Cytiva.

From Cytiva Life Sciences 24 Jun 2020

Reagents News and Research

Novel label-free imaging method can differentiate active T cells from those off duty

Alternative amplification technique could accelerate COVID-19 testing

New approach could enable wider adoption of COVID-19 testing for diagnosis in research laboratories

Ultivue and OracleBio partner to help advance personalized tumor characterization and clinical oncology research using multiplex immunofluorescence

States search for ways to deal with COVID-19 testing backlogs

Avacta provides update on clinical validation of Adeptrix COVID-19 diagnostic test

Avacta provides update on clinical validation of Adeptrix COVID-19 diagnostic test

Promega Maxwell Extraction System added to CDC COVID-19 diagnostic protocol

New assay improves detection of SARS-CoV-2 antibodies

Avacta and Integumen team up for detection of novel coronavirus in waste water

Absolute Antibody and University of Zurich partner to offer novel SARS-CoV-2 sybodies

Fully automated chip can reliably determine blood type within minutes

LGC acquires The Native Antigen Company, strengthening its offer to the IVD sector

Horizon Discovery introduces Cas9 and dCas9-VPR stable cell lines to simplify and accelerate CRISPR gene editing workflows

Cancer Research UK and Abcam launch custom partnership to accelerate cancer research

New tool to increase accessibility for COVID-19 testing

Study: Even the sickest COVID-19 patients produce T cells that help fight the virus

BATM provides business and trading update

Kerafast offers the Delta-G-VSV Pseudotyping System for coronavirus research

Avacta provides update on COVID-19 rapid antigen test development partnership with Cytiva

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News